Barr Will Begin First Self-Sponsored Clinical Trial For An NDA This Fall
Executive Summary
Barr Labs will begin clinical trials on a prostate cancer therapy this fall, the first time it will be conducting its own clinical trials, Barr CEO Bruce Downey said during an Aug. 10 teleconference.
You may also be interested in...
Mylan To File CNS NDAs/ANDAs By Year End Via Synthon Deal
Mylan will file several NDAs and ANDAs for central nervous system treatments over the next two months as part of its collaboration with the Dutch pharmaceutical firm Synthon.
Mylan To File CNS NDAs/ANDAs By Year End Via Synthon Deal
Mylan will file several NDAs and ANDAs for central nervous system treatments over the next two months as part of its collaboration with the Dutch pharmaceutical firm Synthon.
Gabapentin ANDA Comparing Tabs To Caps Is Not Complete, Petition Says
An ANDA for gabapentin tablets that references Warner-Lambert's Neurontin capsules should be treated by the agency as "not substantially complete," an Aug. 12 citizen's petition to FDA argues.